Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Irinotecan (CPT-11) is a drug used against a wide variety of tumors, which can cause severe toxicity, possibly leading to the delay or suspension of the cycle, with the consequent impact on the prognosis of survival. The main goal of this work is to predict the toxicities derived from CPT-11 using artificial intelligence methods. The data for this study is conformed of 53 cycles of FOLFIRINOX, corresponding to patients with metastatic colorectal cancer. Supported by several demographic data, blood markers and pharmacokinetic parameters resulting from a non-compartmental pharmacokinetic study of CPT-11 and its metabolites (SN-38 and SN-38-G), we use machine learning techniques to predict high degrees of different toxicities (leukopenia, neutropenia and diarrhea) in new patients. We predict high degree of leukopenia with an accuracy of 76%, neutropenia with 75% and diarrhea with 91%. Among other variables, this study shows that the areas under the curve of CPT-11, SN-38 and SN-38-G play a relevant role in the prediction of the studied toxicities. The presented models allow to predict the degree of toxicity for each cycle of treatment according to the particularities of each patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Top 10 algorithms in data mining
Wu, X., Kumar, V., Ross Quinlan, J., Ghosh, J., Yang, Q., Motoda, H., McLachlan, G. J., Ng, A., Liu, B., Yu, P. S., et al. (2008) · Knowledge and Information Systems · doi:10.1007/s10115-007-0114-2 · Cited by 5,667
Bozdogan, H. (1987) · Psychometrika · doi:10.1007/bf02294361 · Cited by 4,468
de Man, F. M., Goey, A. K. L., van Schaik, R. H. N., Mathijssen, R. H. J., & Bins, S. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0644-7 · Cited by 421
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity.
Xu, Y., & Villalona-Calero, M. A. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf337 · Cited by 413
Cited by
Irinotecan: 25 years of cancer treatment
Bailly, C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104398 · Cited by 456
Artificial Intelligence in Colorectal Cancer Screening, Diagnosis and Treatment. A New Era
Mitsala, A., Tsalikidis, C., Pitiakoudis, M., Simopoulos, C., & Tsaroucha, A. K. (2021) · Current Oncology · doi:10.3390/curroncol28030149 · Cited by 271
Toxicity prediction based on artificial intelligence: A multidisciplinary overview
Pérez Santín, E., Rodríguez Solana, R., González García, M., García Suárez, M. D. M., Blanco Díaz, G. D., Cima Cabal, M. D., Moreno Rojas, J. M., & López Sánchez, J. I. (2021) · WIREs Computational Molecular Science · doi:10.1002/wcms.1516 · Cited by 153
Dhiman, P., Ma, J., Andaur Navarro, C. L., Speich, B., Bullock, G., Damen, J. A. A., Hooft, L., Kirtley, S., Riley, R. D., Van Calster, B., et al. (2022) · BMC Medical Research Methodology · doi:10.1186/s12874-022-01577-x · Cited by 140
Dhiman, P., Ma, J., Andaur Navarro, C. L., Speich, B., Bullock, G., Damen, J. A. A., Hooft, L., Kirtley, S., Riley, R. D., Van Calster, B., et al. (2023) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2023.03.012 · Cited by 41
Metadata
- Authors
- Oyaga-Iriarte, E., Insausti, A., Sayar, O., & Aldaz, A.
- Venue
- Journal of Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 140
- Issue
- 1
- Pages
- 20-25
- ISSN
- 1347-8613 (ISSN-L)
- OpenAlex
- W2944184830
- Cited by
- 49
- References
- 5
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.